, : Rising global prevalence of obesity and diabetes Strong clinical success of GLP-1 receptor agonists Growing investments from leading pharmaceutical companies Expansion into cardiovascular and metabolic health indications Increasing demand for effective long-term weight management solutions Breakthrough therapies from global innovators are reshaping how metabolic diseases are managed
During this experience, I chose not to workout (to eliminate another variable) and didnt go on any type of diet
PlexusDx recommends monitoring thyroid function and other relevant hormonal markers during treatment, especially if underlying thyroid or reproductive concerns exist
For injection technique guidance, see the subcutaneous vs intramuscular injection guide
van Baar MJB, van Ruiten CC, Muskiet MHA, van Bloemendaal L, IJzerman RG, van Raalte DH